Hepatosplenic T-cell lymphoma in inflammatory bowel disease: A possible thiopurine-induced chromosomal abnormality

American Journal of Gastroenterology

Volumn 105, Issue 10, 2010, Pages 2299-2301

  Kotlyar, David S ^a,b   Blonski, Wojciech ^b,c   Diamond, Robert H ^d   Wasik, Mariusz ^b   Lichtenstein, Gary R ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

^d CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; INFLIXIMAB; MERCAPTOPURINE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TUMOR NECROSIS FACTOR INHIBITOR;

CHROMOSOME 13; CHROMOSOME 7; CHROMOSOME 7Q; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION Y; COCHRANE LIBRARY; CYTOGENETICS; DISEASE ASSOCIATION; DNA DAMAGE; ENTERITIS; HEPATOSPLENIC T CELL LYMPHOMA; HUMAN; LETTER; LIVER CANCER; MEDLINE; PRIORITY JOURNAL; SPLEEN CANCER; T CELL LYMPHOMA; TRISOMY 8; UNIVERSITY HOSPITAL; Y CHROMOSOME; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; CHROMOSOME DISORDER; GENETICS; INFLAMMATORY BOWEL DISEASES; PATHOLOGY; SPLEEN TUMOR;

6-MERCAPTOPURINE; CHROMOSOME DISORDERS; HUMANS; INFLAMMATORY BOWEL DISEASES; LYMPHOMA, T-CELL; SPLENIC NEOPLASMS;

EID: 77957836758     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.213     Document Type: Letter

References (8)

1. Knipp S, Hildebrandt B, Richter J et al. Secondarymyelodysplastic syndromes following treatmentwith azathioprine are associated withaberrations of chromosome 7. Haematologica 2005; 90: 691-3. (Pubitemid 40780892)
2. Kotlyar D, Blonski W, Mendizabal Met al. 958 Case report of trisomy 13 in bonemarrow in a case of hepatosplenic T-celllymphoma (HSTCL) and inflammatorybowel disease (IBD). Gastroenterology 2009; 136: A-146.
3. Kotlyar D, Blonski W, Porter DL et al. S1133 Hepatosplenic T-Cell lymphoma (HSTCL)and Inflammatory bowel disease (IBD):a rare complication aft er long-term thiopurineexposure: case report and systematic reviewof the literature. Gastroenterology 2009; 136: A-196-7.
4. Falchook GS, Vega F, Dang NH et al. Hepatosplenicgamma-delta T-cell lymphoma:clinicopathological features and treatment. AnnOncol 2009; 20: 1080-5.
5. Data on file. Centocor Ortho Biotech.
6. Beaugerie L, Brousse N, Bouvier AM et al.Lymphoproliferative disorders in patientsreceiving thiopurines for inflammatorybowel disease: a prospective observationalcohort study. Lancet 2009; 374:1617-25.
7. Loftus Jr EV. Clinical epidemiology of Inflammatorybowel disease: incidence, prevalence,and environmental influences. Gastroenterology 2004; 126: 1504-17.
8. Fowler S, Beyak M, Depew WT et al. W1212Hepatosplenic T-Cell Lymphoma in Crohn'sDisease. Where does the risk lie? Gastroenterology 2010; 138(5)S1: S-675.